
Catapult Ventures
Description
Catapult Ventures is a well-established UK-based venture capital firm, founded in 2002 and operating from Enderby. The firm specializes in providing equity capital to small and medium-sized enterprises (SMEs) primarily across the UK, with a strong emphasis on the Midlands region. Their investment strategy is geared towards supporting growth, facilitating management buy-outs (MBOs), and providing development capital to businesses poised for expansion across various sectors including manufacturing, technology, business services, healthcare, and consumer.
Catapult Ventures manages several significant funds, often in collaboration with regional and national initiatives. Notable examples include their role as fund manager for the Midlands Engine Investment Fund (MEIF) Equity Finance and Debt Finance funds, which are designed to boost economic growth across the Midlands. They also manage specialized initiatives like the East Midlands Niche Vehicle Network Fund, demonstrating a targeted approach to specific industry sectors. Their focus is typically on established businesses with proven track records and strong management teams, rather than very early-stage startups.
The firm's typical first-cheque investments range from £50,000 to £2 million. Converting this to US dollars (using an approximate exchange rate of 1 GBP = 1.27 USD), this equates to investments between approximately $63,500 and $2.54 million. Catapult Ventures takes a proactive role with its portfolio companies, offering strategic guidance and operational support to help them achieve their growth objectives. Their long-standing presence and commitment to regional economic development have made them a key player in the UK's SME funding landscape.
Investor Profile
Catapult Ventures has backed more than 100 startups, with 3 new investments in the last 12 months alone. The firm has led 23 rounds, about 23% of its total and boasts 29 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series Unknown, Seed, Series A rounds (top funding stages).
- Majority of deals are located in United Kingdom, United States, Israel.
- Strong thematic focus on Biotechnology, Health Care, Software.
- Led 1 rounds in the past year.
- Typical check size: $63.5K – $2.5M.
Stage Focus
- Series Unknown (65%)
- Seed (18%)
- Series A (7%)
- Series B (4%)
- Pre Seed (2%)
- Corporate Round (1%)
- Private Equity (1%)
- Series C (1%)
- Series D (1%)
Country Focus
- United Kingdom (85%)
- United States (14%)
- Israel (1%)
Industry Focus
- Biotechnology
- Health Care
- Software
- Medical
- Health Diagnostics
- Pharmaceutical
- Medical Device
- Robotics
- Manufacturing
- Clinical Trials
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.